Advancing Kidney Care and Research in Canada

CANN-NET will improve the care and outcomes of patients with kidney disease by:

  • Establishing priorities for new guidelines and knowledge translation activities,
  • Identifying knowledge gaps in kidney disease that can be addressed through randomized trials
  • Translating best evidence into clinical practice guidelines
  • Disseminating evidence in guidelines to health care providers caring for people with kidney disease to improve care and outcomes
  • Facilitating the conduct of new clinical trials in kidney disease through a collaborative network of Nephrology researchers

Learn more about CANN-NET


Canadian Nephrology Trials Network (CNTN) / Reseau canadien d’essais cliniques en nephrology (RCEN)


Who are we?

We are a national collaborative network of clinical and translational investigators, community nephrologists, allied health personnel, and patients working together to improve the quantity and quality of prospective clinical studies and randomized trials in nephrology in Canada in order to benefit patients with kidney disease.



The initial priority areas for CANN-NET, as identified by medical and administrative leads of renal programs across Canada, include optimal timing of dialysis initiation, and increasing the appropriate use of home dialysis.  

CANN-NET is grateful to its many committee members and partners, including the Canadian Society of Nephrology, the Kidney Foundation of Canada, the Canadian Society of Transplantation, the Canadian Association of Pediatric Nephrologists, the Renal Pharmacists Network, the Canadian Hypertension Education Program, the Australasian Kidney Trials Network, and the Canadian Network and Centre for Trials Internationally.